Cargando…

Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy

Patients with non-transfusion-dependent thalassemia (NTDT) are at risk of developing brain ischemia. Transcranial Doppler (TCD) has been established as a useful screening tool of cerebrovascular disease in patients with sickle cell disease. Proteins neuron specific enolase (NSE) and S100B are biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanavaki, Aikaterini, Spengos, Konstantinos, Moraki, Maria, Delaporta, Polyxeni, Kariyannis, Catherine, Papassotiriou, Ioannis, Kattamis, Antonis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751325/
https://www.ncbi.nlm.nih.gov/pubmed/29244749
http://dx.doi.org/10.3390/ijms18122724
_version_ 1783289925480742912
author Kanavaki, Aikaterini
Spengos, Konstantinos
Moraki, Maria
Delaporta, Polyxeni
Kariyannis, Catherine
Papassotiriou, Ioannis
Kattamis, Antonis
author_facet Kanavaki, Aikaterini
Spengos, Konstantinos
Moraki, Maria
Delaporta, Polyxeni
Kariyannis, Catherine
Papassotiriou, Ioannis
Kattamis, Antonis
author_sort Kanavaki, Aikaterini
collection PubMed
description Patients with non-transfusion-dependent thalassemia (NTDT) are at risk of developing brain ischemia. Transcranial Doppler (TCD) has been established as a useful screening tool of cerebrovascular disease in patients with sickle cell disease. Proteins neuron specific enolase (NSE) and S100B are biomarkers that reflect CNS injury. The purpose of this study is to evaluate cerebral vessel vasculopathy and brain damage in NTDT patients using non-invasive methods as TCD and measurement serum levels of NSE and S100B. We included in our study 30 patients with NTDT, aged between 8 and 62 years old (mean: 29.4, median: 32) who presented in our Unit for regular follow-up. We performed in all patients a non-imaging TCD examination and have measured serum S100, NSE and lactate dehydrogenase (LDH) levels. We investigated the possible correlation between TCD results and S100B, NSE and LDH levels as well as between NSE-LDH and S100B-LDH levels by regression analysis. We found a statistically significant relationship for both NSE, S100B with LDH. We also found a statistically significant relationship for S100B and time-averaged mean velocity (TAMV)/peak velocity of left middle cerebral artery (MCA), NSE and pulsatility index (PI)/resistive index (RI) of the left posterior cerebral artery (PCA). TCD results correlated with biomarkers for brain ischemia. This finding enhances the role of TCD as a screening tool for brain ischemia in patients with NTDT.
format Online
Article
Text
id pubmed-5751325
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57513252018-01-08 Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy Kanavaki, Aikaterini Spengos, Konstantinos Moraki, Maria Delaporta, Polyxeni Kariyannis, Catherine Papassotiriou, Ioannis Kattamis, Antonis Int J Mol Sci Article Patients with non-transfusion-dependent thalassemia (NTDT) are at risk of developing brain ischemia. Transcranial Doppler (TCD) has been established as a useful screening tool of cerebrovascular disease in patients with sickle cell disease. Proteins neuron specific enolase (NSE) and S100B are biomarkers that reflect CNS injury. The purpose of this study is to evaluate cerebral vessel vasculopathy and brain damage in NTDT patients using non-invasive methods as TCD and measurement serum levels of NSE and S100B. We included in our study 30 patients with NTDT, aged between 8 and 62 years old (mean: 29.4, median: 32) who presented in our Unit for regular follow-up. We performed in all patients a non-imaging TCD examination and have measured serum S100, NSE and lactate dehydrogenase (LDH) levels. We investigated the possible correlation between TCD results and S100B, NSE and LDH levels as well as between NSE-LDH and S100B-LDH levels by regression analysis. We found a statistically significant relationship for both NSE, S100B with LDH. We also found a statistically significant relationship for S100B and time-averaged mean velocity (TAMV)/peak velocity of left middle cerebral artery (MCA), NSE and pulsatility index (PI)/resistive index (RI) of the left posterior cerebral artery (PCA). TCD results correlated with biomarkers for brain ischemia. This finding enhances the role of TCD as a screening tool for brain ischemia in patients with NTDT. MDPI 2017-12-15 /pmc/articles/PMC5751325/ /pubmed/29244749 http://dx.doi.org/10.3390/ijms18122724 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kanavaki, Aikaterini
Spengos, Konstantinos
Moraki, Maria
Delaporta, Polyxeni
Kariyannis, Catherine
Papassotiriou, Ioannis
Kattamis, Antonis
Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy
title Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy
title_full Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy
title_fullStr Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy
title_full_unstemmed Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy
title_short Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy
title_sort serum levels of s100b and nse proteins in patients with non-transfusion-dependent thalassemia as biomarkers of brain ischemia and cerebral vasculopathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751325/
https://www.ncbi.nlm.nih.gov/pubmed/29244749
http://dx.doi.org/10.3390/ijms18122724
work_keys_str_mv AT kanavakiaikaterini serumlevelsofs100bandnseproteinsinpatientswithnontransfusiondependentthalassemiaasbiomarkersofbrainischemiaandcerebralvasculopathy
AT spengoskonstantinos serumlevelsofs100bandnseproteinsinpatientswithnontransfusiondependentthalassemiaasbiomarkersofbrainischemiaandcerebralvasculopathy
AT morakimaria serumlevelsofs100bandnseproteinsinpatientswithnontransfusiondependentthalassemiaasbiomarkersofbrainischemiaandcerebralvasculopathy
AT delaportapolyxeni serumlevelsofs100bandnseproteinsinpatientswithnontransfusiondependentthalassemiaasbiomarkersofbrainischemiaandcerebralvasculopathy
AT kariyanniscatherine serumlevelsofs100bandnseproteinsinpatientswithnontransfusiondependentthalassemiaasbiomarkersofbrainischemiaandcerebralvasculopathy
AT papassotiriouioannis serumlevelsofs100bandnseproteinsinpatientswithnontransfusiondependentthalassemiaasbiomarkersofbrainischemiaandcerebralvasculopathy
AT kattamisantonis serumlevelsofs100bandnseproteinsinpatientswithnontransfusiondependentthalassemiaasbiomarkersofbrainischemiaandcerebralvasculopathy